SKINSYNC
DEAD

Serial Number

98848940

Owner

Encap Hive Pty Ltd

Attorney

Montra Yazdani

Filing Date

Nov 12, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SKINSYNC Trademark

Serial Number: 98848940

SKINSYNC is a trademark filed by Encap Hive Pty Ltd on November 12, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Encap Hive Pty Ltd (2 trademarks)

104 William St
Five Dock NSW2046 , AU

Entity Type: 99

Trademark Details

Filing Date

November 12, 2024

Registration Date

Not Registered

Goods & Services

adhesive patches for medical purposes, namely adhesive patches including a biodegradable electrospun nanofibrous mat containing an active ingredient for dermal delivery for Anti-Inflammation, Chronic and Acute Pain, Neural Diseases such as Dementia or Alzheimer's, Hormonal Application (hormone replacement therapy), Smoking Cessation, Cardiac and Blood Diseases (blood pressure and angina), Anti-Nausea (motion sickness), Chronic Respiratory Diseases and Rhinitis, Overactive Bladder, or Depression and Mental Health; vitamin and supplement patches, namely adhesive patches including a biodegradable electrospun nanofibrous mat containing one or more vitamins or supplements for dermal delivery for Vitamin Deficiencies, General Wellbeing, Boosting Energy, and Recovery and Support; transdermal patches that facilitate the delivery of CBD, namely adhesive patches including a biodegradable electrospun nanofibrous mat containing a hemp-derived THC-free CBD preparation for dermal delivery; patches containing pharmaceutical preparations, namely adhesive patches including a biodegradable electrospun nanofibrous mat containing the pharmaceutical preparation for dermal delivery for Anti-Inflammation, Chronic and Acute Pain, Neural Diseases such as Dementia or Alzheimer's, Hormonal Application (hormone replacement therapy), Smoking Cessation, Cardiac and Blood Diseases (blood pressure and angina), Anti-Nausea (motion sickness), Chronic Respiratory Diseases and Rhinitis, Overactive Bladder, or Depression and Mental Health; any CBD in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing for use with cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 19, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 19, 2026 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 3, 2025 GNFN
FINAL REFUSAL E-MAILED
Dec 3, 2025 GNFR
FINAL REFUSAL WRITTEN
Dec 3, 2025 CNFR
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Oct 31, 2025 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Oct 31, 2025 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 23, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 23, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 23, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 23, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 23, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 22, 2025 DOCK
ASSIGNED TO EXAMINER
Apr 22, 2025 DOCK
ASSIGNED TO EXAMINER
Apr 16, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 12, 2024 NWOS
NEW APPLICATION ENTERED
Nov 12, 2024 NWAP